TT
ABBV icon

Tower Trust’s AbbVie ABBV Stock Holding History

Tower Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$834K Buy
16,236
+253
+2% +$12.8K 0.53% 53
2013
Q4 		$844K Buy
15,983
+442
+3% +$21.7K 0.51% 57
2013
Q3 		$695K Sell
15,541
-216
-1% -$9.57K 0.47% 62
2013
Q2 		$652K Buy
+15,757
New +$689K 0.47% 64

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Tower Trust's ABBV Position: Q1 2014 in Review

Tower Trust increased its AbbVie (ABBV) stake by 1.6% in Q1 2014, buying an estimated $12.8K and bringing the position to 16,236 shares worth $834K. The position accounts for 0.53% of the portfolio, ranked #53.

Tower Trust first reported a position in ABBV in Q2 2013 and has held it in 4 quarters since. The position peaked at $844K in Q4 2013. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • Tower Trust held 16,236 shares of AbbVie worth $834K as of Q1 2014.
  • Tower Trust bought 253 AbbVie shares in Q1 2014, an estimated $12.8K.
  • AbbVie made up 0.53% of Tower Trust's portfolio in Q1 2014, its #53 holding.
  • Tower Trust first reported a position in AbbVie in Q2 2013 and has held it in 4 quarters since.
  • Tower Trust's AbbVie position peaked at $844K in Q4 2013.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on Tower Trust's 13F filing for Q1 2014, filed 8 May 2014.